Award
Delivery Order #SPE2DR26F5DB3
AmerisourceBergen Delivery Order for Testosterone Gel Within Ongoing IDV
Buyer
Defense Logistics Agency
Ceiling
$59.36
Awarded
February 13, 2026
Period of Performance
Feb 13, 2026 – Feb 17, 2026
Identifier
SPE2DR26F5DB3
NAICS
325411
This award represents a delivery order contract under the existing Indefinite Delivery Vehicle (IDV) agreement with AmerisourceBergen Drug Corporation, a leading global pharmaceutical services provider. The contract focuses on the procurement and delivery of a testosterone 1.62% gel pump, a specialized pharmaceutical product intended for patient treatment. This delivery order is part of a multi-year, long-term agency contract that ensures reliable and timely access to critical medications, reinforcing the agency's pharmaceutical supply chain stability. The scope includes the procurement and distribution of this specific hormonal gel in Conshohocken, Pennsylvania, over a short performance period in early 2026. The award is linked to a significant parent IDV contract that facilitates continued pharmaceutical distribution services, highlighting AmerisourceBergen's key role in supporting healthcare logistics. The delivery order was likely issued under competitive mechanisms allowed within the IDV framework, enabling efficient and responsive acquisition. As a supplement to the established contract vehicle, this delivery order underscores ongoing agency commitments to healthcare product availability without the need for a separate competitive bid for each order.
Description
4570820542!TESTOSTERONE 1.62% GEL PUMP 75GM